SMA
MRNA icon

Sage Mountain Advisors’s Moderna MRNA Stock Holding History

Sage Mountain Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-910
Closed -$231K – 674
2021
Q4 		$231K Buy
910
+123
+16% +$36K 0.03% 496
2021
Q3 		$303K Sell
787
-308
-28% -$114K 0.04% 360
2021
Q2 		$257K Buy
+1,095
New +$196K 0.04% 340

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sage Mountain Advisors's MRNA Position: Q1 2022 in Review

Sage Mountain Advisors sold out of Moderna (MRNA) in Q1 2022, closing a stake of 910 shares — an estimated $231K sold.

Sage Mountain Advisors first reported a position in MRNA in Q2 2021 and held it in 3 quarters. The position peaked at $303K in Q3 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Sage Mountain Advisors reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • Sage Mountain Advisors sold 910 Moderna shares in Q1 2022, an estimated $231K.
  • Sage Mountain Advisors first reported a position in Moderna in Q2 2021 and held it in 3 quarters.
  • Sage Mountain Advisors's Moderna position peaked at $303K in Q3 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Sage Mountain Advisors's 13F filing for Q1 2022, filed 10 May 2022.